Analysis Article • Aug 08
Have your own idea? Try our Stock Screener
Spanish (IBEX) Healthcare Sector Analysis
UpdatedAug 28, 2026
DataAggregated Company Financials
Companies13
- 7D1.0%
- 3M0.05%
- 1Y-5.8%
- YTD-7.4%
Over the last 7 days, the Healthcare industry has risen 1.0%, driven by gains from Laboratorios Farmaceuticos Rovi of 2.7%. In the past year, the industry is down 5.8%. As for the next few years, earnings are expected to grow by 23% per annum.
Sector Valuation and Performance
Has the Spanish Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 28 Aug 2026 | €16.2b | €11.4b | €841.8m | 20.2x | 19.3x | 1.4x |
| Sun, 26 Jul 2026 | €16.0b | €11.4b | €824.4m | 17.3x | 19.4x | 1.4x |
| Tue, 23 Jun 2026 | €15.4b | €11.3b | €750.1m | 21.2x | 20.5x | 1.4x |
| Thu, 21 May 2026 | €16.4b | €11.3b | €750.0m | 21.3x | 21.9x | 1.4x |
| Sat, 18 Apr 2026 | €18.2b | €11.4b | €747.8m | 22.5x | 24.3x | 1.6x |
| Mon, 16 Mar 2026 | €16.7b | €11.4b | €776.9m | 19.4x | 21.5x | 1.5x |
| Wed, 11 Feb 2026 | €18.4b | €11.3b | €706.2m | 31.7x | 26x | 1.6x |
| Fri, 09 Jan 2026 | €18.2b | €11.3b | €706.2m | 28.8x | 25.7x | 1.6x |
| Sun, 07 Dec 2025 | €16.9b | €11.3b | €700.8m | 25.3x | 24.1x | 1.5x |
| Tue, 04 Nov 2025 | €16.9b | €11.2b | €614.7m | 25.7x | 27.5x | 1.5x |
| Thu, 02 Oct 2025 | €17.8b | €11.1b | €621.8m | 25.8x | 28.6x | 1.6x |
| Sat, 30 Aug 2025 | €17.1b | €11.1b | €610.7m | 25.1x | 28x | 1.5x |
| Mon, 28 Jul 2025 | €17.1b | €11.0b | €503.5m | 21.2x | 33.9x | 1.6x |
| Wed, 25 Jun 2025 | €15.6b | €11.0b | €507.4m | 21.4x | 30.7x | 1.4x |
| Fri, 23 May 2025 | €15.2b | €11.0b | €507.1m | 22.6x | 29.9x | 1.4x |
| Sun, 20 Apr 2025 | €13.5b | €10.8b | €458.2m | 19.6x | 29.4x | 1.2x |
| Tue, 18 Mar 2025 | €14.9b | €10.8b | €458.8m | 19.9x | 32.4x | 1.4x |
| Thu, 13 Feb 2025 | €14.4b | €10.6b | €392.4m | 17.1x | 36.7x | 1.4x |
| Sat, 11 Jan 2025 | €14.4b | €10.6b | €392.4m | 19.7x | 36.8x | 1.4x |
| Mon, 09 Dec 2024 | €14.2b | €10.6b | €392.5m | 19.7x | 36.2x | 1.3x |
| Wed, 06 Nov 2024 | €16.1b | €10.3b | €391.6m | 24.5x | 41.1x | 1.6x |
| Fri, 04 Oct 2024 | €15.4b | €10.2b | €394.8m | 15.1x | 38.9x | 1.5x |
| Sun, 01 Sep 2024 | €15.5b | €10.2b | €399.9m | 14.9x | 38.7x | 1.5x |
| Tue, 30 Jul 2024 | €15.4b | €10.0b | €412.0m | 20.1x | 37.5x | 1.5x |
| Thu, 27 Jun 2024 | €15.0b | €10.0b | €405.8m | 19.8x | 36.8x | 1.5x |
| Sat, 25 May 2024 | €15.5b | €10.0b | €396.3m | 19.3x | 39.1x | 1.5x |
| Mon, 22 Apr 2024 | €13.6b | €10.0b | €297.6m | 17.4x | 45.7x | 1.4x |
| Wed, 20 Mar 2024 | €13.2b | €10.0b | €289.0m | 20.9x | 45.5x | 1.3x |
| Fri, 16 Feb 2024 | €14.7b | €10.0b | €331.9m | 18.2x | 44.4x | 1.5x |
| Sun, 14 Jan 2024 | €13.5b | €10.0b | €332.6m | 17.2x | 40.5x | 1.3x |
| Tue, 12 Dec 2023 | €16.2b | €10.0b | €332.5m | 17.1x | 48.7x | 1.6x |
| Thu, 09 Nov 2023 | €14.5b | €9.9b | €311.1m | 16.2x | 46.5x | 1.5x |
| Sat, 07 Oct 2023 | €14.8b | €9.8b | €302.1m | 18.6x | 48.8x | 1.5x |
| Mon, 04 Sep 2023 | €15.4b | €9.8b | €311.0m | 19.4x | 49.5x | 1.6x |
Price to Earnings Ratio
49.5x
Current Industry PE
- Investors are pessimistic on the Spanish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 19.3x which is lower than its 3-year average PE of 34.2x.
- The industry is trading close to its 3-year average PS ratio of 1.5x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 39% per year over the last three years.
- Revenues for these companies have grown 5.5% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Spanish Healthcare sector?
| ES Market | 0.33% | |
| Healthcare | 1.01% | |
| Pharma | 1.32% | |
| Healthcare Services | 0.92% | |
| Biotech | 0.81% | |
| Life Sciences | 0% | 0 |
| Medical Equipment | -1.50% | |
Industry PE
- Investors are most optimistic about the Pharma industry even though it's trading below its 3-year average PE ratio of 27.6x.
- Analysts are expecting annual earnings growth of 17.3%, which is lower than the prior year's growth of 40.0% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 106% over the next 5 years.
- This is better than its past earnings growth rate of 18% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 17% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ROVI Laboratorios Farmaceuticos Rovi | €60.85 | 1.8% +€53.7m | 4.9% | PE16.8x | |
| GRF Grifols | €9.95 | 0.4% +€25.9m | -17.6% | PE15x | |
| ATRY Atrys Health | €2.56 | 1.0% +€1.9m | -10.0% | PS1.3x | |
| RJF Laboratorio Reig Jofre | €2.71 | 0.7% +€1.6m | -1.5% | PE31.8x |